Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
Piśmiennictwo
1.FujiiK.,MiyashitaT.:Gorlinsyndrome(nevoidbasalcellcarcinomasyndrome):updateandliteraturereview.PediatricsInternational
2014;56:667-674.
2.PellegriniC.,MaturoM.G.,DiNardoL.iwsp.:Understandingthemoleculargeneticsofbasalcellcarcinoma.
InternationalJournalofMolecularSciences2017;18(11):2485.
3.BolshakovS.,WalkerC.M.,StromS.S.iwsp.:p53mutationsin
humanaggressiveandnonaggressivebasalandsquamouscellcarcinomas.ClinicalCancerResearch2003;9(1):228-234.
4.Bo-
nillaX.,ParmentierL.,KingB.iwsp.:Genomicanalysisidentifiesnewdriversandprogressionpathwaysinskinbasalcellcarcinoma.
NatureGenetics2016;48(4):398-406.
5.StagnerA.M.,JakobiecF.A.:Updatesonthemolecularpathologyofselectedocularand
ocularadnexaltumors:potentialtargetsforfuturetherapy.SeminarsinOphthalmology2016;31(1-2):188-196.
6.BhaijeeF.,Brown
A.S.:Muir-Torresyndrome.ArchivesofPathologyandLaboratoryMedicine2014;138(12):1685-1689.
7.ShalinS.C.,LyleS.,Calonje
E.iwsp.:SebaceousneoplasiaandtheMuir-Torresyndrome:importantconnectionswithclinicalimplications.Histopathology2010;
56(1):133-147.
8.HussainR.M.,MatthewsJ.L.,DubovyS.R.iwsp.:UV-independentp53mutationsinsebaceouscarcinomaofthe
eyelid.OphthalmicPlasticandReconstructiveSurgery2014;30(5):392-395.
9.KiyosakiK.,NakadaC.,HijiyaN.iwsp.:Analysisof
p53mutationsandtheexpressionofp53andp21WAF1/CIP1proteinin15casesofsebaceouscarcinomaoftheeyelid.Investigative
Ophthalmology&VisualScience2010;51(1):7-11.
10.KumarA.,KumarDorairajS.,PrabhakaranV.C.iwsp.:Identificationofgenes
associatedwithtumorigenesisofmeibomiancellcarcinomabymicroarrayanalysis.Genomics2007;90(5):559-566.
11.UchiH.:Merkelcellcarcinoma:anupdateandimmunotherapy.FrontiersinOncology2018;8:48.
12.BeckerJ.C.:Merkel
cellcarcinoma.AnnalsofOncology2010;21(Suppl.7):vii81-vii5.
13.SimbiriK.O.,MurakamiM.,FeldmanM.iwsp.:Multipleoncoge-
nicvirusesidentifiedinOcularsurfacesquamousneoplasiainHIV-1patients.InfectiousAgentsandCancer2010;5:6.
14.Gichuhi
S.,SagooM.S.,WeissH.A.iwsp.:EpidemiologyofocularsurfacesquamousneoplasiainAfrica.TropicalMedicineandInternational
Health2013;18(12):1424-1443.
15.LehmannA.R.,McGibbonD.,StefaniniM.:Xerodermapigmentosum.OrphanetJournalofRare
Diseases2011;1:6-70.
16.GuptaN.,SachdevR.,TandonR.:Ocularsurfacesquamousneoplasiainxerodermapigmentosum:clini-
calspectrumandoutcome.Graefe’sArchiveforClinicalandExperimentalOphthalmology2011;249(8):1217-1221.
17.Griewank
K.G.,WestekemperH.,MuraliR.iwsp.:ConjunctivalmelanomasharborBRAFandNRASmutationsandcopynumberchangessimilar
tocutaneousandmucosalmelanomas.ClinicalCancerResearch2013;19(12):3143-3152.
18.LakeS.L.,JmorF.,DopieralaJ.iwsp.:
Multiplexligation-dependentprobeamplificationofconjunctivalmelanomarevealscommonBRAFV600Egenemutationandgene
copynumberchanges.InvestigativeOphthalmology&VisualScience2011;52(8):5598-5604.
19.KirkegaardM.M.,RasmussenP.K.,
CouplandS.E.iwsp.:Conjunctivallymphoma-aninternationalmulticenterretrospectivestudy.JAMAOphthalmology2016;134(4):
406-414.
20.CerroneM.,CollinaF.,DeChiaraA.iwsp.:BCL10expressionandlocalizationinocularadnexaMALTlymphomas:acom-
parativecytogeneticandimmunohistochemicalstudy.HistologyandHistopathology2014;29(1):77-87.
21.RuizA.,ReischlU.,SwerdlowS.H.iwsp.:ExtranodalmarginalzoneB-celllymphomasoftheocularadnexa:multiparameter
analysisof34casesincludinginterphasemolecularcytogeneticsandPCRforChlamydiapsittaci.AmericanJournalofSurgicalPatho-
logy2007;31(5):792-802.
22.StreubelB.,VinatzerU.,LamprechtA.iwsp.:T(3;14)(p14.1;q32)involvingIGHandFOXP1isanovel
recurrentchromosomalaberrationinMALTlymphoma.Leukemia2005;19(4):652-658.
23.BettsD.R.,LeibundgutK.E.,NiggliF.K.:
Cytogeneticanalysisinacaseofintraocularmedulloepithelioma.CancerGeneticsandCytogenetics1996;92(2):144-146.
24.Priest
J.R.,WilliamsG.M.,ManeraR.iwsp.:Ciliarybodymedulloepithelioma:fourcasesassociatedwithpleuropulmonaryblastoma-areport
fromtheInternationalPleuropulmonaryBlastomaRegistry.BritishJournalofOphthalmology2011;95(7):1001-1005.
25.Shields
J.A.,EagleR.C.Jr,FergusonK.iwsp.:Tumorsofthenonpigmentedepitheliumoftheciliarybody:theLorenzE.ZimmermanTribute
Lecture.Retina2015;35(5):957-965.
26.JakobiecF.A.,KoolM.,StagnerA.M.iwsp.:Intraocularmedulloepitheliomasandembryonal
tumorswithmultilayeredrosettesofthebrain:comparativerolesofLIN28AandC19MC.AmericanJournalofOphthalmology2015;
159(6):1065-1074.
27.Rodriguez-GalindoC.,OrbachD.B.,VanderVeenD.:Retinoblastoma.PediatricClinicsofNorthAmerica2015;
62(1):201-223.
28.KnudsonA.G.Jr.:Mutationandcancer:statisticalstudyofretinoblastoma.ProceedingsoftheNationalAcademy
ofSciencesoftheUnitedStatesofAmerica.1971;68(4):820-823.
29.RushlowD.,PiovesanB.,ZhangK.iwsp.:Detectionofmosaic
RB1mutationsinfamilieswithretinoblastoma.HumanMutation2009;30(5):842-851.
30.DommeringC.J.,MolB.M.,MollA.C.iwsp.:
RB1mutationspectruminacomprehensivenationwidecohortofretinoblastomapatients.JournalofMedicalGenetics2014;51(6):
366-374.
31.RushlowD.E.,MolB.M.,KennettJ.Y.iwsp.:CharacterisationofretinoblastomaswithoutRB1mutations:genomic,gene
expression,andclinicalstudies.LancetOncology2013;14(4):327-334.
32.FarquharN.,ThorntonS.,CouplandS.E.iwsp.:Patterns
ofBAP1proteinexpressionprovideinsightsintoprognosticsignificanceandthebiologyofuvealmelanoma.JournalofPathology.
ClinicalResearch2017;4(1):26-38.
33.KaliraiH.,DodsonA.,FaqirS.iwsp.:LackofBAP1proteinexpressioninuvealmelanomais
associatedwithincreasedmetastaticriskandhasutilityinroutineprognostictesting.BritishJournalofCancer2014111(7):1373-1380.
34.DamatoB.,DopieralaJ.A.,CouplandS.E.:Genotypicprofilingof452choroidalmelanomaswithmultiplexligation-dependentprobe
amplification.ClinicalCancerResearch2010;16(24):6083-6092.
35.HöglundM.,GisselssonD.,HansenG.B.iwsp.:Dissectingka-
ryotypicpatternsinmalignantmelanomas:temporalclusteringoflossesandgainsinmelanomakaryotypicevolution.International
JournalofCancer2004;108(1):57-65.
36.HarbourJ.W.:Thegeneticsofuvealmelanoma:anemergingframeworkfortargeted
Piśmiennictwo
25
